Novo Nordisk, as the patent holder for semaglutide, would under normal conditions have a protected monopoly for the sale of its drug products
Concurrent use may produce excessive nausea, vomiting, dizziness, or mood changes that neither drug alone would cause at standard doses
[42] Incretins such as semaglutide and other GLP-1 RA cause a decrease in blood sugar levels once released by the gastrointestinal tract
Vomiting was reported in 12% of the 12mg group
Two to three years of continuous use can add up to 3,500 to 9,000 or more
What's Inside YourProtocol EpitalON Each capsule contains: Active Ingredient: Ala-Glu-Asp-Gly tetrapeptide complex: 3mg per capsule Other Ingredients: Rice flour (bulking agent), Vegetable cellulose capsule, May contain additional excipients for stability Free From: Synthetic fillers, Artificial additives, Preservatives, Gluten, Dairy, Soy YourProtocol EpitalON is manufactured in a cGMP-certified facility in the United States and undergoes third-party testing for purity and potency